Tabula Rasa HealthCare to Participate in Upcoming J.P. Morgan Investor Conference
Tabula Rasa HealthCare (TRHC) announced participation in the 39th Annual J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Tabula Rasa HealthCare (TRHC) announced participation in the 39th Annual J.P. Morgan Healthcare Conference, scheduled to be held virtually from January 11-14, 2021. CEO Calvin H. Knowlton and other executives will present on January 14, 2021, at 4:30 p.m. EST. An audio replay will be accessible on their investor relations website. TRHC specializes in patient medication safety solutions that enhance medication regimens and reduce risks related to adverse drug events, leveraging its MedWise™ technology to improve patient outcomes and lower healthcare costs.
Details
News Market Reaction – TRHC
The recorded move for TRHC in the trading session of this news was -1.00%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MOORESTOWN, N.J., Dec. 29, 2020 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), today announced CEO, Chairman and Founder, Calvin H. Knowlton, Ph.D.; Co-Founder, President, Chief Marketing and Business Development Officer, Orsula V. Knowlton, PharmD; Chief Sales Officer, Kevin Boesen; and Chief Financial Officer, Brian W. Adams, will participate in the 39th Annual J.P. Morgan Healthcare Conference to be held virtually January 11-14, 2021.
The TRHC presentation is scheduled for Thursday, January 14, 2021 at 4:30 p.m. EST. An audio replay of the presentation will be available at https://ir.tabularasahealthcare.com/.
About Tabula Rasa HealthCare
Tabula Rasa HealthCare (TRHC) provides patient medication safety solutions empowering pharmacists and prescribers to optimize medication regimens and reduce medication-related risk, specifically targeting adverse drug events. Utilizing its proprietary medication decision science technology, MedWise™, TRHC improves patient outcomes, reduces hospitalizations, and lowers healthcare costs. TRHC also provides an extensive clinical pharmacy and telepharmacy network across the U.S. Our solutions are trusted by health plans and pharmacies to help drive value-based payment results. For more information, visit TRHC.com.
Tabula Rasa HealthCare Investor Relations Contact:
Frank Sparacino
Senior Vice President, Investor Relations and Corporate Development
fsparacino@trhc.com
T: (312) 451-2157
Tabula Rasa HealthCare Media Contact:
Dianne Semingson
dsemingson@trhc.com
T: (215) 870-0829
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.